← All trials
NCT05766267
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2023
- Primary completion
- Oct 30, 2024
- Completion date
- Apr 30, 2026
- First posted
- Mar 13, 2023
- Last posted
- Mar 13, 2023
- Enrollment
- 288
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Centers for Disease Control and Prevention (CDC)Study chair
- Johns Hopkins UniversityStudy chair
- Cornell UniversityStudy chair
- Johns Hopkins UniversityOfficial
- Centers for Disease Control and Prevention (CDC)Official
- Cornell UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.